Figure 4
From: FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
2D structures of DRV and the scaffold of DRV analogs with different substitutions on the P1, P1′, P2, and P2′ positions, where the chemical structures of modified functional groups (1–20) at each position are shown below.
